Easton Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. The company was founded by John K. Easton on February 4, 1997 and is headquartered in Toronto, Canada.
Company profile
Ticker
EAPH
Exchange
Website
CEO
Evan Karras
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Lam Pharmaceutical Corp, Lam Pharmiceutical Corp
SEC CIK
Corporate docs
EAPH stock data
Latest filings (excl ownership)
10-K/A
2020 FY
Annual report (amended)
29 Dec 21
10-K/A
2019 FY
Annual report (amended)
29 Dec 21
10-Q
2021 Q3
Quarterly report
22 Dec 21
10-Q
2021 Q2
Quarterly report
22 Dec 21
10-Q
2021 Q1
Quarterly report
22 Dec 21
10-K
2020 FY
Annual report
22 Dec 21
Latest ownership filings
No filings
Institutional ownership, Q2 2022
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 10.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
SignalPoint Asset Management | 10.00 k | $0.00 |